Company news

NeoGenomics, Inc. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

NeoGenomics Reports Revenue of $121 Million in the Third Quarter

November 3, 2021

NeoGenomics Announces Leadership Team Transition

November 3, 2021

NeoGenomics' Liquid Biopsy Subsidiary Inivata Announces Clinical Collaboration With Princess Margaret Cancer Center for the Use of Its Liquid Biopsy Assays

October 18, 2021

NeoGenomics Schedules its Third Quarter 2021, Earnings Release for November 4, 2021

October 12, 2021

NeoGenomics Announces Board of Directors' Transition

October 11, 2021

NeoGenomics' Liquid Biopsy Subsidiary Inivata and Collaborators to Present Data that Further Validate the Application of its RaDaR(TM) MRD and InVisionFirst(R)-Lung Assays at the ESMO Congress 2021

September 8, 2021

NeoGenomics to Participate in the Morgan Stanley 19th Annual Global Healthcare Conference

August 31, 2021

NeoGenomics Reports 40% Revenue Growth to $122 Million in the Second Quarter

August 5, 2021

NeoGenomics Schedules its Second Quarter 2021 Earnings Release for August 6, 2021

July 13, 2021

NeoGenomics Completes Inivata Acquisition - Combining Best-In-Class Liquid Biopsy Technology with Leading Community Oncology Platform

June 17, 2021

NeoGenomics To Participate Virtually In Multiple Upcoming Institutional Investor Conferences

May 26, 2021

NeoGenomics To Participate In The Bank of America 2021 Health Care Conference

May 9, 2021

NeoGenomics to Acquire Inivata - Combining Best-In-Class Liquid Biopsy Technology with Leading Community Oncology Platform

May 4, 2021

NeoGenomics Reports 9% Revenue Growth to $116 Million in the First Quarter

May 4, 2021

NeoGenomics Announces the Launch of Biomarker Assist KRAS Single Gene Testing (SGT) Program for Advanced or Metastatic (Stage IV) Non-Small Cell Lung Cancer Patients

April 18, 2021

NeoGenomics to Participate in the 20th Annual Needham Virtual Healthcare Conference

April 12, 2021

NeoGenomics Schedules its First Quarter 2021 Earnings Release for May 5, 2021

April 6, 2021

NeoGenomics Agrees to Acquire Trapelo Health

March 23, 2021

NeoGenomics and Elevation Oncology Announce Collaboration to Expand Genomic Testing for NRG1 Fusions Across Solid Tumors in Support of the Phase 2 CRESTONE Study

March 15, 2021

Elevation Oncology and NeoGenomics Announce Collaboration to Expand Genomic Testing for NRG1 Fusions Across Solid Tumors in Support of the Phase 2 CRESTONE Study

March 15, 2021

NeoGenomics To Participate In The Virtual Raymond James 42nd Annual Institutional Investors Conference

February 28, 2021

NeoGenomics To Participate In The Virtual 10th Annual SVB Leerink Global Healthcare Conference

February 24, 2021

NeoGenomics Reports 18% Revenue Growth to $126 Million in the Fourth Quarter

February 23, 2021

NeoGenomics Announces CEO Succession

February 23, 2021

NeoGenomics to Participate in the BTIG Virtual Medtech, Digital Health, Life Science & Diagnostic Tools Conference

February 15, 2021

NeoGenomics Schedules its Fourth Quarter and Full Year 2020 Earnings Release for February 24, 2021

February 4, 2021

Parexel and NeoGenomics Announce Strategic Collaboration in Precision Medicine to Improve Study Designs and Accelerate Patient Matching in Oncology Clinical Trials

February 3, 2021

NeoGenomics Announces Pricing of Public Offerings of Common Stock and Convertible Senior Notes

January 5, 2021

NeoGenomics Announces Proposed Public Offerings of Common Stock and Convertible Senior Notes

January 4, 2021

NeoGenomics To Virtually Participate In The 39th Annual J.P. Morgan Healthcare Conference

January 3, 2021

NeoGenomics To Virtually Participate In Fireside Chat At The Stephens Annual Investment Conference 2020

November 12, 2020

NeoGenomics to Offer Mobile Phlebotomy Services for Liquid Biopsy Tests

November 8, 2020

NeoGenomics Reports Revenue Growth of 20% to Record $125 Million in the Third Quarter

October 26, 2020

NeoGenomics Announces Plans to Expand Global Footprint in Pharma Services by Opening Clinical Research Laboratory in Suzhou, China

October 12, 2020

NeoGenomics Schedules Its Third Quarter Earnings Release for October 27, 2020

September 30, 2020

NeoGenomics To Virtually Participate In Fireside Chat At The 18th Annual Morgan Stanley Global Healthcare Conference

September 9, 2020

NeoGenomics Reports Revenue of $87 Million in the Second Quarter amid COVID-19 Pandemic

July 27, 2020

NeoGenomics Announces Board Appointments

July 19, 2020

NeoGenomics Schedules its Second Quarter Earnings Release for July 28, 2020

June 30, 2020

NeoGenomics Launches Comprehensive Suite of Solid Tumor Liquid Biopsy Tests for Cancer Patients

June 28, 2020

NeoGenomics To Virtually Present At The Raymond James Human Health Innovation Conference

June 1, 2020

NeoGenomics To Virtually Participate In Fireside Chat At The 40th Annual William Blair Growth Stock Conference

May 31, 2020

NeoGenomics To Virtually Participate In 17th Annual Craig-Hallum Institutional Investor Conference

May 25, 2020

NeoGenomics Enters Strategic Collaboration with Inivata to Commercialize InVisionFirst(R)-Lung Liquid Biopsy Test

May 25, 2020

NeoGenomics To Virtually Participate In Fireside Chat At BofA Securities 2020 Health Care Conference

May 10, 2020

NeoGenomics and Bayer Collaborate to Offer NTRK Testing for Certain Colorectal and Thyroid Cancer Patients

May 4, 2020

NeoGenomics Reports 11% Revenue Growth to $106 Million in the First Quarter

April 27, 2020

NeoGenomics Provides COVID-19 Business Update

April 8, 2020

NeoGenomics Integrates HALO(R) From Indica Labs

April 2, 2020

NeoGenomics Schedules its First Quarter Earnings Release for April 28, 2020

March 31, 2020

← Newer news releases · Older news releases →

Calls

The 5 newest of 22 calls. Every call is listed under its year.

Decks

The 5 newest of 40 decks. Every deck is listed under its year.